Abeona Therapeutics Inc Profit margin
What is the Profit margin of Abeona Therapeutics Inc?
The Profit margin of Abeona Therapeutics Inc is -1,548.23%
What is the definition of Profit margin?
Profit margin is a measure of profitability and is calculated by finding the net profit as a percentage of the revenue.
lfy (last fiscal year)
Profit margin is calculated with the selling price (or revenue) taken as base times 100. It is the percentage of selling price that is turned into profit. Profit percentages are calculated to find the ratio of profit to cost of an investment. Profit margin is an indicator of a company's pricing strategies and how well it controls costs. Differences in competitive strategy and product mix cause the profit margin to vary among different companies. The profit margin is used mostly for internal comparisons. It is difficult to accurately compare the net profit ratio for different entities. Individual businesses' operating and financing arrangements vary so much that different entities are bound to have different levels of expenditure, so that comparison of one with another can have little meaning. A low profit margin indicates a low margin of safety: higher risk that a decline in sales will erase profits and result in a net loss, or a negative margin.
Profit margin of companies in the Health Care sector on NASDAQ compared to Abeona Therapeutics Inc
What does Abeona Therapeutics Inc do?
abeona therapeutics inc. (nasdaq: $abeo), is a leading clinical-stage biopharmaceutical company focused on developing novel gene therapies for life-threatening rare genetic diseases. abeona was forged from the company’s close collaborations with key stakeholders all dedicated to transforming new biotechnology insights into breakthrough treatments for rare diseases. abeona's lead programs include abo-102 (aav-sgsh), an adeno-associated virus (aav) based gene therapy for sanfilippo syndrome type a (mps iiia) and eb-101 (gene-corrected skin grafts) for recessive dystrophic epidermolysis bullosa (rdeb). abeona is also developing abo-101 (aav-naglu) for sanfilippo syndrome type b (mps iiib), abo-201 (aav-cln3) gene therapy for juvenile batten disease (jncl), abo-202 (aav-cln1) for treatment of infantile batten disease (incl), eb-201 for epidermolysis bullosa (eb), abo-301 (aav-fancc) for fanconi anemia (fa) disorder and abo-302 using a novel crispr/cas9-based gene editing approach to gene t
Companies with profit margin similar to Abeona Therapeutics Inc
- Cadiz has Profit margin of -1,579.41%
- Argenica Therapeutics has Profit margin of -1,578.84%
- Societe d'Exploration Miniere Vior has Profit margin of -1,575.34%
- Valbiotis SA has Profit margin of -1,568.15%
- Pacific Bauxite has Profit margin of -1,562.71%
- GOME Retail has Profit margin of -1,554.68%
- Abeona Therapeutics Inc has Profit margin of -1,548.23%
- TUT Fitness has Profit margin of -1,546.30%
- Precigen Inc has Profit margin of -1,540.63%
- Papyrus Australia has Profit margin of -1,530.61%
- Bluma Wellness has Profit margin of -1,527.43%
- Armata Pharmaceuticals Inc has Profit margin of -1,524.51%
- Emmerson Resources has Profit margin of -1,514.62%